澳门永利娱场官方网·(中国区)最新官方网站

DNA Methylation Detection Kit for Human SDC2, SEPTIN9 and TFPI2 Gene -- COLC (Colorectal Cancer)

DNA Methylation Detection Kit for Human PCDH17, POU4F2 and PENK Gene -- BLAC (Bladder Cancer)

DNA Methylation Detection Kit for Human PAX1, SOX1 and HAS1 Gene -- CERC (Cervical Cancer)

DNA Methylation Detection Kit for Human SDC2, SEPTIN9 and TFPI2 Gene -- COLC (Colorectal Cancer)

Clinical Application

Colorectal cancer (CRC) affects millions of people worldwide. It is unique in that it progresses slowly, making it

preventable, and mortality can be significantly reduced through early detection. Testing using stool samples is more appropriate for screening efforts than colonoscopy because it is easier to conduct the program. Simultaneous testing with FIT not only greatly improves sensitivity and specificity, but is also more acceptable for widespread screening, or home sampling.

DNA Methylation can be a novel marker of prognosis for tumor therapy, which is also a reversible process in which inactivated tumor suppressor genes are expressed through demethylation to exert a tumor suppressor effect. Therefore, demethylation can be used as a new direction in cancer treatment to monitor the dynamics of the disease.

Intended Use

This kit is a real-time PCR assay for qualitative detection of DNA methylation in gene SDC2, SEPTIN9 and TFPI2 Gene in human genomic DNA extracted from stool sample.